Dover (DOV) Q1 2026 earnings review
Surging Bookings Support a Clean Breakout for 2026
Dover started 2026 with accelerating momentum, delivering 10% top-line growth (5.3% organic) and an 11% increase in Adjusted EPS to $2.28. After a sluggish first three quarters of 2025, the growth trajectory is decisively shifting upwards. What stands out most is the order book: consolidated bookings spiked 24% YoY to $2.46 billion, generating a massive 1.20 book-to-bill ratio. While international markets and a couple of specific segments lagged, the explosive recovery in Climate & Sustainability and Clean Energy & Fueling fully offset the weakness. Management reaffirmed its double-digit full-year EPS growth guidance, and the backlog absolutely supports it.
🐂 Bull Case
Bookings hit $2.46 billion, far outpacing the $2.05 billion in recognized revenue. A 1.20 book-to-bill ratio across the portfolio heavily de-risks the remainder of the year and confirms demand remains robust despite macro noise.
Climate & Sustainability Technologies (DCST) and Clean Energy & Fueling (DCEF) suffered in early 2025 from destocking and delayed CapEx. They have now violently reversed into growth mode, posting 15.2% and 11.1% organic growth, respectively.
🐻 Bear Case
The entire growth story is currently sitting on the shoulders of the U.S. market (+12.1% organic). Meanwhile, Europe (-4.2%) and Asia (-4.7%) are contracting, indicating highly fractured global macro demand.
Despite management touting secular growth in biopharma and data center cooling, the Pumps & Process segment—Dover's most profitable unit—posted negative organic growth (-0.8%) this quarter. If this engine stalls, total margin expansion will be difficult.
⚖️ Verdict: 🟢
Bullish. The sheer volume of bookings ($2.46 billion) overshadows the localized weakness in international markets. A 1.20 book-to-bill ratio is a rare and highly positive indicator for an industrial manufacturer of this scale.
Key Themes
Bookings Surge Provides Exceptional Visibility
Consolidated bookings accelerated dramatically, reaching $2.46 billion in Q1—a 24% year-over-year increase compared to $1.99 billion in 25Q1. This isn't isolated to one product; management noted the book-to-bill ratio was well above 1.0 in all five segments. This effectively locks in significant revenue for Q2 and Q3, insulating the company from short-term macro shocks.
Climate & Sustainability Lead the Turnaround
The Climate & Sustainability segment has officially reversed its 2025 slump. Dragged down previously by a massive freeze in food retail refrigeration orders (which cost the company roughly 1.5-2.0% of total organic growth in 2025), the segment just posted 15.2% organic growth. The deferred CapEx cycle has clearly broken open.
U.S. Demand Bailing Out the Global Portfolio
The macro picture is highly bifurcated. Organic growth was exclusively driven by the United States, which surged an impressive 12.1% organically. The 'proximity manufacturing' model Dover implemented allows them to capitalize on domestic demand and infrastructure spending without being severely hindered by international shipping or tariff bottlenecks.
Contradiction in the Secular Growth Narrative
Management has spent the last year highlighting data center liquid cooling (thermal connectors) and single-use biopharma as their secular growth superstars, housed within the Pumps & Process Solutions segment. Yet, this segment just posted an organic revenue decline of -0.8%. While Q1 2025 was a tough restocking comparison, a negative organic print contradicts the uninterrupted 'double-digit growth' narrative sold to investors.
Broad International Contraction
The macro setup outside the Americas is deteriorating. Organic revenue fell 4.2% in Europe and 4.7% in Asia. While US strength covered the gap this quarter, any future deceleration in North America would leave the company exposed, as the rest of the globe is actively shrinking.
Imaging & Identification Losing Ground
Imaging & ID was the weakest performing segment, decelerating to a -3.3% organic contraction. While the segment maintained a very healthy 28.6% adjusted EBITDA margin, the loss of top-line momentum in a business previously praised for stability and fast-moving consumable dynamics is a point to monitor.
Other KPIs
Stable. Total adjusted segment EBITDA margin came in at 24.1%, holding flat against 24.0% in 25Q1. Pumps & Process continues to lead profitability with a massive 34.1% margin, ensuring that even with slight organic volume declines, the bottom line is fiercely protected.
Accelerating slightly compared to the $109.3 million generated in 25Q1. Operating Cash Flow hit $191.0 million, demonstrating healthy conversion relative to net income. Despite elevated bookings requiring working capital builds for upcoming quarters, cash generation remains robust.
Guidance
Accelerating. The midpoint of $10.55 implies nearly 10% year-over-year growth against FY25's $9.61. This aligns with Dover's long-term double-digit EPS growth targets and indicates extreme confidence in margin preservation and share buyback impacts.
Accelerating. Implies organic growth of 3.0% to 5.0%, with acquisitions and favorable currency translation providing the remaining lift. Given the 5.3% organic print in Q1 and the massive bookings backlog, this guidance range looks highly achievable, if not conservative.
Key Questions
Pumps & Process Organic Decline
With Pumps & Process organic growth turning negative (-0.8%) in Q1, how much of this was strictly due to the difficult biopharma restocking comp from early 2025 versus any actual moderation in data center thermal cooling demand?
International Market Weakness
Europe and Asia both posted mid-single-digit organic declines this quarter. Are these declines isolated to specific segments like vehicle services and can-making, or are you seeing a broader industrial recession in those regions?
Converting Backlog to Revenue
You generated a massive $2.46 billion in bookings this quarter. Given ongoing supply chain and capacity optimization efforts, what is the expected cadence for converting this record order book into recognized revenue throughout the rest of 2026?